These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33190719)

  • 61. Multitarget stool DNA testing for colorectal-cancer screening.
    Lee JK; Terdiman JP; Corley DA
    N Engl J Med; 2014 Jul; 371(2):186. PubMed ID: 25006739
    [No Abstract]   [Full Text] [Related]  

  • 62. Multitarget stool DNA testing for colorectal-cancer screening.
    Senore C; Segnan N
    N Engl J Med; 2014 Jul; 371(2):185-6. PubMed ID: 25006738
    [No Abstract]   [Full Text] [Related]  

  • 63. Multitarget stool DNA testing for colorectal-cancer screening.
    Brenner H; Werner S; Chen H
    N Engl J Med; 2014 Jul; 371(2):184-5. PubMed ID: 25006737
    [No Abstract]   [Full Text] [Related]  

  • 64. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH
    N Engl J Med; 2014 Jul; 371(2):187-8. PubMed ID: 25006736
    [No Abstract]   [Full Text] [Related]  

  • 65. [Experience with screening for carcinoma of the uterine cervix and the possibilities for its optimal detection].
    Halko I
    Cesk Gynekol; 1987 Nov; 52(9):671-5. PubMed ID: 3447724
    [No Abstract]   [Full Text] [Related]  

  • 66. Cervical cancer screening in Europe - changes over the last 9 years.
    Ronco G; Anttila A
    Eur J Cancer; 2009 Oct; 45(15):2629-31. PubMed ID: 19695869
    [No Abstract]   [Full Text] [Related]  

  • 67. Screening for cervical cancer--future perspectives.
    Andreassen T; Vogt C
    Tidsskr Nor Laegeforen; 2014 Jun; 134(11):1122-3. PubMed ID: 24939773
    [No Abstract]   [Full Text] [Related]  

  • 68. Self-sampling for HPV to enhance uptake of cervical cancer screening: Has the time come in Canada?
    Lofters A; Vahabi M
    CMAJ; 2016 Sep; 188(12):853-854. PubMed ID: 27114490
    [No Abstract]   [Full Text] [Related]  

  • 69. Cervical cancer screening trends, 1992-2000.
    J Natl Cancer Inst; 2003 Mar; 95(6):424. PubMed ID: 12644531
    [No Abstract]   [Full Text] [Related]  

  • 70. Radioisotopes in preliminary screening of cervical cancer.
    Nodine JH; Chang SC; Holmes R; Lewis G; Fletcher M
    J Nucl Med; 1974 Sep; 15(9):733-8. PubMed ID: 4137155
    [No Abstract]   [Full Text] [Related]  

  • 71. Public awareness and cervical cancer screening.
    Davies P
    Cytopathology; 2012 Jun; 23(3):143-5. PubMed ID: 22587553
    [No Abstract]   [Full Text] [Related]  

  • 72. Preliminary report on a new method of mass screening by colposcopy for early detection of cancer of the cervix in a New York City family planning center.
    Cimber HS
    J Reprod Med; 1971 Jul; 7(1):31-2. PubMed ID: 5150922
    [No Abstract]   [Full Text] [Related]  

  • 73. Can "DNA-based stool tests" replace colonoscopy in screening for colon cancer?
    Danalıoğlu A
    Turk J Gastroenterol; 2014 Feb; 25(1):122-3. PubMed ID: 24918149
    [No Abstract]   [Full Text] [Related]  

  • 74. Key indicators of organized cancer screening programs: Results from a Delphi study.
    Csanádi M; de Kok IM; Heijnsdijk EA; Anttila A; Heinävaara S; Pitter JG; Széles G; Ivanuš U; Priaulx J; Veerus P; Senore C; Koning HJ; Vokó Z
    J Med Screen; 2019 Sep; 26(3):120-126. PubMed ID: 30621498
    [No Abstract]   [Full Text] [Related]  

  • 75. Barriers in cervical cancer screening programs in new European Union member states.
    Anttila A; Arbyn M; Veerus P; Viberga I; Kurtinaitiene R; Valerianova Z; Apostol I; Baili P; Micheli A
    Tumori; 2010; 96(4):515-6. PubMed ID: 20968128
    [No Abstract]   [Full Text] [Related]  

  • 76. [Specification for quality control of cervical cancer screening (DB11/T 2137-2023)].
    Beijing Obstetrics and Gynecology Hospital, Capital Medical University/Beijing Maternal and Child Health Care Hospital
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):269-273. PubMed ID: 38644264
    [No Abstract]   [Full Text] [Related]  

  • 77. Somatic mutations and CRISPR/Cas9 library screening integrated analysis identifies cervical cancer drug-resistant pathways.
    Cao C; Liu T; Zhang Q; Li R; Zeng Z; Cui Z; Wang X; Gong D; Tian X; Hu Z
    Clin Transl Med; 2021 Dec; 11(12):e632. PubMed ID: 34911161
    [No Abstract]   [Full Text] [Related]  

  • 78. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.
    Vaccarella S; Franceschi S; Bray F; Wild CP; Plummer M; Dal Maso L
    N Engl J Med; 2016 Aug; 375(7):614-7. PubMed ID: 27532827
    [No Abstract]   [Full Text] [Related]  

  • 79. Novel blood-based early cancer detection: diagnostics in development.
    Beer TM
    Am J Manag Care; 2020 Nov; 26(14 Suppl):S292-S299. PubMed ID: 33200893
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The IARC Perspective on Cervical Cancer Screening.
    Suba EJ; Ortega RE; Mutch DG
    N Engl J Med; 2022 Feb; 386(6):607. PubMed ID: 35139284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.